The outlook of companies tied to Sildenafil's legacy presents a intricate investment scenario . While the initial surge generated substantial returns , generic competition have significantly diminished https://bookmarkblast.com/story21721205/copyright-s-flagship-product-and-pharma-a-uncertain-venture